<DOC>
	<DOC>NCT00968019</DOC>
	<brief_summary>The purpose of this study is: To evaluate the safety and performance of the Presillion stent in routine clinical practice.</brief_summary>
	<brief_title>Multicenter Postmarket Surveillance Registry Evaluating Performance and Long Term Safety of the Presillion Stent</brief_title>
	<detailed_description>Primary endpoint: Composite of Major Adverse Cardiac Events (MACE), which includes cardiac death, myocardial infarction (Q-wave and non Q-wave) and clinically driven target lesion revascularization (TLR) at 12 months follow-up. Data will be collected on 400 patients (from 14 hospitals in Spain and Portugal) treated with the Presillion stent in up to 2 de novo native coronary artery lesions Study design: multicenter, prospective, observational</detailed_description>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>All subjects treated with Presillion stent up to two de novo coronary artery lesions No specified</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>